Apogee Therapeutics (APGE) Depreciation and Depletion (2024 - 2026)
Apogee Therapeutics (APGE) reported Depreciation and Depletion of $400000.0 for Q1 2026, up 100.0% year-over-year from $200000.0 in Q1 2025, and down 1.48% on a QoQ basis from $406000.0 in Q4 2025.
Apogee Therapeutics (APGE) has 3 years of Depreciation and Depletion data on file, last reported at $400000.0 in Q1 2026.
- Quarterly Depreciation and Depletion rose 100.0% year-over-year to $400000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 318.23% YoY) and the FY2025 annual result came in at $1.4 million, up 609.0% from the prior year.
- Depreciation and Depletion eased to $400000.0 in Q1 2026 per APGE's latest filing, from $406000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $406000.0 in Q4 2025 and bottomed at $29000.0 in Q1 2024.
- The 3-year median for Depreciation and Depletion is $200000.0 (2025), against an average of $224333.3.
- The widest annual swing landed in 2025, when Depreciation and Depletion soared 1011.11%; it then surged 100.0% in 2026.
- Tracing APGE's Depreciation and Depletion over 3 years: stood at $100000.0 in 2024, then soared by 306.0% to $406000.0 in 2025, then fell by 1.48% to $400000.0 in 2026.
- Per Business Quant, the three latest APGE Depreciation and Depletion figures stand at $400000.0 (Q1 2026), $406000.0 (Q4 2025), and $400000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Apogee Therapeutics | 5.53 Bn | 4.47 Bn | - | 400,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 400,000.00 |
| Mar 31, 2026 | 400,000.00 |
| Dec 31, 2025 | 406,000.00 |
| Dec 31, 2025 | 406,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 48,000.00 |
| Sep 30, 2024 | 48,000.00 |
| Jun 30, 2024 | 36,000.00 |
| Jun 30, 2024 | 36,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Mar 31, 2024 | 29,000.00 |